State of Alaska Department of Revenue’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
VVM
BOCH
CWG
YIH
State of Alaska Department of Revenue's LENZ Position: Q2 2026 in Review
State of Alaska Department of Revenue increased its LENZ Therapeutics (LENZ) stake by 54% in Q2 2026, buying an estimated $105K and bringing the position to 37,159 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1649.
State of Alaska Department of Revenue first reported a position in LENZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $306K in Q4 2025. 66 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.
- State of Alaska Department of Revenue held 37,159 shares of LENZ Therapeutics worth $211K as of Q2 2026.
- State of Alaska Department of Revenue bought 13,000 LENZ Therapeutics shares in Q2 2026, an estimated $105K.
- LENZ Therapeutics made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1649 holding.
- State of Alaska Department of Revenue first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 3 quarters since.
- State of Alaska Department of Revenue's LENZ Therapeutics position peaked at $306K in Q4 2025.
- 66 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.